Accrol Group Holdings PLC Appointment of Non Executive Director (4868D)
10 October 2018 - 5:00PM
UK Regulatory
TIDMACRL
RNS Number : 4868D
Accrol Group Holdings PLC
10 October 2018
10 October 2018
Accrol Group Holdings plc
("Accrol Group", the "Company" or, together with its
subsidiaries, the "Group")
AIM: ACRL
Appointment of Non-executive Director
Accrol Group, the UK's leading independent tissue converter,
announces that Simon Allport, aged 54, has been appointed to the
Board as an independent non-executive Director.
Simon has 32 years' experience in the professional services
industry, first making partner at Arthur Andersen and rising to
managing partner for the North of England and Scotland at Ernst
& Young. He retired from Ernst & Young in 2017 and has
since taken a small number of non-executive and consultancy
roles.
Simon joins the Audit Committee with immediate effect.
The Board now comprises:
-- Dan Wright (Executive Chairman)
-- Gareth Jenkins (Chief Executive Officer)
-- Steve Townsley (Chief Financial Officer)
-- Joanne Lake (Independent Non-Executive Director)
-- Euan Hamilton (Independent Non-Executive Director)
-- Simon Allport (Independent Non-Executive Director)
Dan Wright, Executive Chairman of Accrol Group, said:
"Simon's appointment increases the capabilities and calibre of
an already much strengthened Board. The depth of his commercial
knowledge and experience, combined with his clear thinking and
direct approach, will be stimulating and valuable, as we accelerate
the turnaround process in H2 and begin to explore the strategic
growth options for the Group. On behalf of everyone at Accrol, I
welcome Simon to the Board."
Information on Simon required to be disclosed under Schedule
Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:
Simon Allport is currently a director of the following
companies:
-- Fitzallan Limited
-- The Enterprise Fund Limited
-- Etale Limited
Simon is also a member of an independent advisory committee for
Tosca Debt Capital LLP.
In addition, Simon was a partner in the following limited
liability partnerships in the past five years:
-- Ernst & Young Europe LLP
-- Ernst & Young LLP
Simon has no interests in the share capital of Accrol Group
Holdings plc.
There is no further information on Simon required to be
disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM
Rules for Companies.
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman Tel: +44 (0) 1254 278 844
Gareth Jenkins, Chief Executive Officer
Steve Townsley, Chief Financial Officer
Zeus Capital Limited (Nominated Adviser
& Broker)
Dan Bate / Andrew Jones Tel: +44 (0) 161 831 1512
Dominic King / John Goold Tel: +44 (0) 203 829 5000
Belvedere Communications Limited
Cat Valentine (cvalentine@belvederepr.com) Tel: +44 (0) 7715 769 078
Llew Angus (langus@belvederpr.com) Tel: +44 (0)7407 023 147
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading
tissue converter and supplier of toilet rolls, kitchen rolls and
facial tissues, as well as other tissue products, to major
discounters and grocery retailers throughout the UK.
Accrol operates from three sites:
-- A manufacturing, storage and distribution facility in Blackburn;
-- A facial tissue plant, also in Blackburn; and
-- A manufacturing, storage and distribution facility in Leyland.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAKKLFBVBFBFBQ
(END) Dow Jones Newswires
October 10, 2018 02:00 ET (06:00 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024
